Skandinaviska Enskilda Banken (SEB)’s Abiomed Inc ABMD Stock Holding History
Bought
Maintained
Sold
Other funds holding ABMD
TRSOTSOK
BTI
IA
AW
HNB
Skandinaviska Enskilda Banken (SEB)'s ABMD Position: Q4 2022 in Review
Skandinaviska Enskilda Banken (SEB) sold out of Abiomed Inc (ABMD) in Q4 2022, closing a stake of 8,028 shares — an estimated $1.97M sold.
Skandinaviska Enskilda Banken (SEB) first reported a position in ABMD in Q2 2018 and held it in 18 quarters. The position peaked at $15.4M in Q1 2019. 8 funds tracked by Wall St. Rank hold ABMD as of Q4 2022.
- Skandinaviska Enskilda Banken (SEB) reported no remaining Abiomed Inc position as of Q4 2022 after selling out during the quarter.
- Skandinaviska Enskilda Banken (SEB) sold 8,028 Abiomed Inc shares in Q4 2022, an estimated $1.97M.
- Skandinaviska Enskilda Banken (SEB) first reported a position in Abiomed Inc in Q2 2018 and held it in 18 quarters.
- Skandinaviska Enskilda Banken (SEB)'s Abiomed Inc position peaked at $15.4M in Q1 2019.
- 8 funds tracked by Wall St. Rank held Abiomed Inc as of Q4 2022.
Based on Skandinaviska Enskilda Banken (SEB)'s 13F filing for Q4 2022, filed 8 Feb 2023.